Cellectar Biosciences (CLRB) Tops Q1 EPS by 30c
Tweet
Share
E-mailGet Alerts CLRB Hot Sheet
Join SI Premium – FREE
Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of $0.11, $0.30 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $89.3 million.
For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Heritage Global to wind down specialty lending unit, expects material charge
- enVVeno Medical (NVNO) Misses Q2 EPS by 537c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
